This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Fennoy, I. Articles by Laraque, D. Search for Related Content PubMed PubMed Citation Articles by Fennoy, I. Articles by Laraque, D. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB SULFAMETHOXAZOLE TRIMETHOPRIM TRIMETHOPRIM/SULFAMETHOXAZOLE Social Bookmarking                   What's this?

Benign Transient Hyperphosphatasia and HIV Infection

Department of Pediatrics, Columbia University at the Harlem Hospital Medical Center, New York, New York

Danielle Laraque, MD

Department of Pediatrics, Columbia University at the Harlem Hospital Medical Center, New York, New York

The disorder, benign transient hyperphosphatasia, has been defined previously as a condition occurring in a normal child with spontaneous, transient elevation of alkaline phosphatase.

We report three cases of hyperphosphatasia in patients with congenital HIV infection and underlying liver disease which appear to satisfy the criteria for benign transient hyperphosphatasia despite the presence of chronic disease. These three children, when compared with three normal children with transient hyperphosphatasia exhibited similar patterns of change in serum alkaline phosphatase.

Extreme elevation of serum alkaline phosphatase in HIV infected patients does not of itself suggest alterations in clinical status nor indicate the need for extensive evaluation.

Clinical Pediatrics, Vol. 28, No. 4, 180-184 (1989)
DOI: 10.1177/000992288902800405


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?